Showing results (21-30 of 496) with videos related to
Sort By:
Pageof 50
American Journal of Epidemiology|July 5, 2012
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Gregory S Calip, Catherine M Tangen, et al.The Journal of Urology|June 14, 2008
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsyIan M Thompson, Catherine M Tangen, Donna P Ankerst, et al.The Journal of Urology|April 18, 2007
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detectionIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.American Journal of Epidemiology|February 10, 2010
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Marian L Neuhouser, et al.Journal of the National Cancer Institute|March 14, 2018
Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention TrialJoseph M Unger, Dawn L Hershman, Cathee Till, et al.The Journal of Urology|April 14, 2012
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECTYair Lotan, Phyllis J Goodman, Ramy F Youssef, et al.American Journal of Epidemiology|May 5, 2011
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Kathryn B Arnold, et al.Controlled Clinical Trials|March 17, 2004
Implementation of the Prostate Cancer Prevention Trial (PCPT)Phyllis J Goodman, Catherine M Tangen, John J Crowley, et al.European Urology Focus|March 21, 2026
Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein ModelEmily A Vertosick, Phyllis Goodman, Catherine M Tangen, et al.Nature Reviews. Urology|June 6, 2009
Clinical trials: 'clinical integration': laudable, but challengingE David Crawford, Catherine M TangenPageof 50